ABVC
ABVC BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.99%Leverage
- Debt / equity
- 0.17x
- Net debt / equity
- 0.17x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.23x
- Net debt / EBITDA
- -0.22x
Liquidity & coverage
- Current ratio
- 0.07x
- Quick ratio
- 0.07x
- Cash ratio
- 0.02x
- Interest coverage
- -47.11x
- EBITDA / interest
- -50.42x
- Working capital
- -$5.3M
Cash & dividend
- FCF / debt
- -1.39x
- Cash flow / debt
- -1.53x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026